 Home > Popular Keywords > Keyword List R > radical therapy cancer

radical therapy cancer

Echemi shares different kinds of information about radical therapy cancer. Maybe you'll get different insights into radical therapy cancer here.

In localized prostate cancer, how to choose external beam radiation therapy and radical prostatectomy? 5 years follow-up data for your reference

 Time of Update: 2022-10-21

Edit: LRReview: LRExecution: LRAfter 5 years of follow-up, the study found that patients in the EBRT-LDR group had more severe urinary irritation/obstruction, worse bowel function, but less urinary incontinence symptoms compared with RP.
Int J Urol: Which is better, radical prostatectomy or external radiation therapy + androgen

 Time of Update: 2022-04-23

Definite treatments for prostate cancer include radical prostatectomy and External radiation therapy, the optimal treatment of prostate tumors is currently unknown due to the lack of clear and well-defined randomized controlled trialsHere, researchers from Hallym University Dongtan Sacred Heart Hospital in South Korea compared the oncological outcomes of patients with clinical T3b prostate cancer who received either radical prostatectomy (RP) or radiotherapy plus androgen deprivation therapy (HT + RT) .
J Urol: Among high-risk and very high-risk prostate cancer patients, which of radical prostatectomy or radiation therapy has a higher survival rate?

 Time of Update: 2021-11-02

They reported on high-risk (HR) patients of the National Comprehensive Cancer Network (NCCN) and Johns Hopkins University (JH) high-risk (HR) and very high-risk (VHR) In the subgroup, the cancer-specific mortality (CSM) of radical prostatectomy (RP) and external radiotherapy (EBRT) were compared .
J Clin Oncol: Effect of neoadjuvant therapy with gemcitabine + cisplatin + pembrolizumab before radical resection of muscular invasive bladder cancer

 Time of Update: 2021-09-03

Phase II Study of Gemcitabine and Split-Dose Cisplatin Plus Pembrolizumab as Neoadjuvant Therapy Before Radical Cystectomy in Patients With Muscle-Invasive Bladder Cancer . 01003Phase II Study of Gemcitabine and Split- Dose Cisplatin Plus Pembrolizumab as Neoadjuvant Therapy Before Radical Cystectomy in Patients With Muscle-Invasive Bladder Cancer in this message

Hot Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

What's trending

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.